LABORATORIO FARMAC.ERFO (RK7) — Net Asset Quality Index
LABORATORIO FARMAC.ERFO (RK7) has a Net Asset Quality Index of 71.7% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €10.52 Million minus total liabilities of €2.98 Million yields net assets of €7.54 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore RK7 current and non-current assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
LABORATORIO FARMAC.ERFO Net Asset Quality Index Over Time (2021–2023)
This chart shows how LABORATORIO FARMAC.ERFO's Net Asset Quality Index has evolved across 3 annual periods from 2021 to 2023. As of June 2024, the index stands at 71.7%, representing net assets of €7.54 Million against total assets of €10.52 Million EUR. See RK7 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for LABORATORIO FARMAC.ERFO (2021–2023)
The table below presents the year-by-year Net Asset Quality Index for LABORATORIO FARMAC.ERFO from 2021 to 2023, covering 3 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see RK7 market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 77.7% | €7.88 Million | €10.15 Million | €2.26 Million | ▲ +77.7 pp |
| 2022 | 0.0% | €0.00 | €10.53 Million | €10.53 Million | ▼ -68.2 pp |
| 2021 | 68.2% | €4.73 Million | €6.93 Million | €2.21 Million | — |